South Korea's pharma exports hit $10B
South Korea's pharmaceutical industry achieved exceptional performance in 2025, with exports surpassing $10.44 billion for the first time—an increase of 12.4% over the previous year—while imports rose by 5.9%. This resulted in a 41.9% increase in the trade surplus, reaching $1.56 billion, driven by strong growth in biotech drug exports, which topped the product categories. Additionally, domestic production reached its highest level since 1998, growing by 3% to approximately $21.5 billion, with companies like Siltiron and Hanmi Pharm posting record revenues.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)